Fisher Wallace Laboratories
Medical Devices for Mood and Sleep
Overview
Raised: $357,719
Rolling Commitments ($USD)
Status
Funded
Reporting Date
09/30/2022
Days Remaining
Funded
% of Min. Goal
3,577%
% of Max. Goal
36%
Likelihood of Max
Funded
Avg. Daily Raise
$12,335
# of Investors
273
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2019
Industry
Fitness & Wellness
Tech Sector
Medtech
Distribution Model
B2B/B2C
Margin
High
Capital Intensity
High
Fisher Wallace Laboratories, with a valuation of $81.2 million, is raising funds on StartEngine. The company manufactures and sells wearable medical devices for mood and sleep disorders, including insomnia, anxiety, and depression. The product of Fisher Wallace Laboratories, Fisher Wallace Stimulator, stimulates the brain to produce serotonin and modulates brainwave activity. The company has generated $40 million in lifetime revenue and has 14,000 prescribers. Kelly Roman and Charles Fisher founded Fisher Wallace Laboratories in August 2019. The current crowdfunding campaign has a minimum target of $9,999.35 and a maximum target of $1,000,084.77. The campaign proceeds will be used to release OAK (Version 2) and expand.
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$4,230,290 |
$4,250,866 |
COGS |
$623,703 |
$970,761 |
Tax |
$250 |
$1,597 |
| ||
| ||
Net Income |
$-3,262,291 |
$-1,823,732 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$1,929,380 |
$695,749 |
Accounts Receivable |
$0 |
$2,302 |
Total Assets |
$1,999,403 |
$853,359 |
Short-Term Debt |
$471,468 |
$725,122 |
Long-Term Debt |
$576,525 |
$620,416 |
Total Liabilities |
$1,047,993 |
$1,345,538 |
Financials as of: 08/03/2022
Create a free account today to gain access to KingsCrowd analytics.
Raise History
Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|---|
Fisher Wallace Laboratories | 02/24/2024 | StartEngine | $100,280,000 | $39,480 | Equity - Common | Active | RegA+ |
Fisher Wallace | 02/20/2023 | StartEngine | $81,567,588 | $1,281,201 | Equity - Common | Funded | RegCF |
Fisher Wallace Laboratories | 09/01/2022 | StartEngine | $81,236,323 | $357,719 | Equity - Common | Funded | RegCF |
Fisher Wallace Laboratories | 05/27/2022 | StartEngine | $80,048,889 | $1,279,724 | Equity - Common | Funded | RegCF |
Fisher Wallace Laboratories | 10/26/2021 | StartEngine | $40,000,000 | $5,010,683 | Equity - Common | Funded | RegA+ |
Fisher Wallace Laboratories | 03/09/2020 | StartEngine | $15,000,000 | $1,056,480 | Equity - Common | Funded | RegCF |
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Are you the founder of Fisher Wallace Laboratories? Create your account today to claim this raise page.